Theradiag S.A. buy krebskrebs
Start price
16.08.21
/
50%
€1.90
Target price
16.08.22
€2.40
Performance (%)
-14.53%
End price
17.08.22
€1.62
Summary
This prediction ended on 17.08.22 with a price of €1.62. The prediction for Theradiag S.A. disappointed with a performance of -14.53%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Theradiag S.A. | - | - | - |
iShares Core DAX® | -0.992% | -3.231% | 11.661% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% |
Comments by krebskrebs for this prediction
In the thread Theradiag S.A. diskutieren
Buy mit Kursziel 2,4
In the thread Trading Theradiag S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten